|
Orthologous residues
|
|
p53 (human): S20‑p, p53 (mouse): S20‑p, p53 iso2 (mouse): S23‑p, p53 (rat): S20‑p, p53 (rabbit): S20‑p, p53 (monkey): S20‑p
|
|
Characterization
|
|
Methods used to characterize site in vivo:
phosphoamino acid analysis, western blotting
|
|
Disease tissue studied:
brain cancer, glioblastoma, glioblastoma multiforme, glioma
|
|
Relevant cell lines - cell types - tissues:
U251 (glial), U373 MG (glial), U87MG (glial)
|
|
Cellular systems studied:
cell lines
|
|
Species studied:
human
|
|
Upstream Regulation
|
|
Treatments, proteins and their effect on site modification:
|
|
Treatments
|
Referenced Treatments
|
Manipulated Protein
|
Referenced Protein
|
Effect
|
Notes
|
|
|
|
p53 (human)
|
|
increase
|
exogenous p53 expressed in mutant p53 cells
|
|
ionizing radiation
|
|
p53 (human)
|
|
increase
|
|
|
cisplatin
|
|
p53 (human)
|
|
increase
|
exogenous p53 expressed in WT p53 cells
|
|
|
Downstream Regulation
|
|
Effect of modification (process):
apoptosis, induced
|